Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Based on Phase 2 safety data (Jastreboff et al., NEJM 2023), common early adverse effects reported include: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea or constipation Reduced appetite Mild fatigue or dizziness These effects are consistent with the GLP-1 receptor agonist class and typically reflect the gut's adaptation to altered gastric emptying and hormonal signalling
Carrots and foods with a lot of beta-carotene may turn urine orange
The safety profile of dual agonists is similar to pure GLP-1 agonists, with the main difference being slightly higher rates of GI side effects
A consumer adhesive patch offers neither a standardized dose nor a proven path across the skin, which is the entire problem in a single sentence
The blend of powerful ingredients in these injections boosts the bodys metabolism, helping burn fat faster
Pricing Disclaimer: Prices mentioned were observed on company websites and press releases as of December 26, 2025
